Show simple item record

dc.contributor.authorMurphy, Richard Aen
dc.contributor.authorSunpath, Henryen
dc.contributor.authorLu, Zhigangen
dc.contributor.authorChelin, Nevilleen
dc.contributor.authorLosina, Elenaen
dc.contributor.authorGordon, Michelleen
dc.contributor.authorRoss, Douglasen
dc.contributor.authorEwusi, Aba Den
dc.contributor.authorMatthews, Lynn Ten
dc.contributor.authorKuritzkes, Daniel Ren
dc.contributor.authorMarconi, Vincent Cen
dc.date.accessioned2012-12-11T23:38:27Z
dc.date.available2012-12-11T23:38:27Z
dc.date.issued2010-04-24
dc.date.submitted2011-03-22
dc.identifier.citationAIDS;2010;24(7):1007-12en
dc.identifier.issn1473-5571
dc.identifier.pmid20397305
dc.identifier.urihttp://hdl.handle.net/10144/255398
dc.descriptionArticle approval pending
dc.description.abstractTo determine initial 24-week outcomes among prospectively enrolled patients with failure of initial antiretroviral therapy (ART).
dc.language.isoenen
dc.relation.urlhttp://journals.lww.com/aidsonline/Abstract/2010/04240/Outcomes_after_virologic_failure_of_first_line_ART.9.aspxen
dc.rightsPublished by Wolters Kluwer Lippincott Williams & Wilkins - Archived on this site by kind permission Wolters Kluweren
dc.subject.meshAdulten
dc.subject.meshAnti-HIV Agentsen
dc.subject.meshAnti-Retroviral Agentsen
dc.subject.meshCD4 Lymphocyte Counten
dc.subject.meshDrug Resistance, Viralen
dc.subject.meshFemaleen
dc.subject.meshGenotypeen
dc.subject.meshHIV Infectionsen
dc.subject.meshHIV-1en
dc.subject.meshHumansen
dc.subject.meshMaleen
dc.subject.meshMiddle Ageden
dc.subject.meshMutationen
dc.subject.meshProspective Studiesen
dc.subject.meshSouth Africaen
dc.subject.meshTreatment Failureen
dc.subject.meshViral Loaden
dc.titleOutcomes After Virologic Failure of First-Line ART in South Africaen
dc.typeArticleen
dc.contributor.departmentOperational Support Unit, Doctors Without Borders, New York, New York; McCord Hospital, Durban, South Africa; Massachusetts General Hospital, Boston, Massachusetts, USA; Nelson Mandela School of Medicine, Durban; St. Mary’s Hospital, Mariannhill, South Africa; Harvard Medical School; Division of Infectious Diseases, Beth Israel Deaconess Medical Center; Section of Retroviral Therapeutics, Brigham and Women’s Hospital, Boston, Massachusetts; Infectious Disease Service, San Antonio Military Medical Center, Fort Sam Houston, Texas; Emory University School of Medicine, Atlanta, Georgia, USAen
dc.identifier.journalAIDSen
refterms.dateFOA2019-03-04T10:07:45Z
html.description.abstractTo determine initial 24-week outcomes among prospectively enrolled patients with failure of initial antiretroviral therapy (ART).


Files in this item

Thumbnail
Name:
Murphy Outcomes after virologic ...
Size:
131.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record